APOC1 antibody (HRP)
Quick Overview for APOC1 antibody (HRP) (ABIN7449300)
Target
See all APOC1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Purpose
- Goat anti-Human Apo CI [H07] Antibody HRP Conjugated
-
Immunogen
- Human Apolipoprotein CI
-
Isotype
- IgG
-
-
-
-
Application Notes
-
WB: 1:1,000 - 1:4,000
ELISA: 1:1,000 - 1:4,000
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 1 mg/mL
-
Buffer
- 50 mM PBS, 0.1 M NaCl, and 0.01 % Thiomersal, pH 7.4
-
Preservative
- Thimerosal (Merthiolate)
-
Precaution of Use
- This product contains Thimerosal (Merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C
-
Expiry Date
- 12 months
-
-
- APOC1 (Apolipoprotein C-I (APOC1))
-
Alternative Name
- ApoCI
-
Background
- Background: ApoCI contains 57 amino acid residues and the m.w. is 6.6 kDa (Jackson et al., 1974). ApoCI has been found to activate LCAT (Liu and Subbaiah 1993). Apo CI is an inhibitor of lipoprotein binding to the LDL receptor, LDL receptor-related protein, and VLDL receptor. Apo CI is also an inhibitor of the plasma cholesteryl ester transfer protein and of fatty acid uptake into tissues (Shachter, 2001). This inhibition role can potentially regulate several lipase enzymes. (Poensgen, 1990, Conde-Knape et al., 2002, Berbee et al., 2005)
-
Gene ID
- 341
-
NCBI Accession
- NP_001636
-
UniProt
- P02654
-
Pathways
- Apoptosis
Target
-